Abstract Background In 2009, Norway initiated routine quadrivalent HPV (qHPV) vaccination
for girls at 12–13 years of age to protect against virus types causing cervical cancer …

Nowadays, the striking numbers of infertile couples that turn to assisted reproductive
technologies (ART) drive the research toward a more comprehensive understanding of the …

Background Oral health care professionals are well positioned to contribute to the
prevention of human papillomavirus (HPV)–related oropharyngeal and other HPV-related …

Purpose: To examine correlates of HPV vaccination uptake in a nationally representative
sample of 18–26-year-old adults. Methods: Young adults aged 18–26 years were identified …

Human papillomavirus (HPV) is currently the most common sexually transmitted disease in
the United States, with potentially serious health consequences, including cervical cancer …

Abstract The World Health Organisation recognised human papillomavirus (HPV) as the
cause of multiple cancers, including head and neck cancers. HPV is a double-stranded DNA …

Uptake of human papillomavirus (HPV) vaccine in the United States (US) is far below the
Healthy People 2020 goal of 80% coverage among adolescents. In rural communities, HPV …

Human Papillomavirus (HPV) vaccination is a well-known fundamental strategy in the
prevention of cervical cancer, as it is always caused by HPV infection. In fact, primary …

The prevalence and distribution of oncogenic human papillomavirus (HPV) genotypes in
women who underwent screening for cervical cancer in the Wielkopolska region, Poland …

Purpose and Objectives The human papillomavirus (HPV) vaccine is an effective but
underused method for preventing multiple cancers, particularly cervical cancer. Although …